OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
December 11, 2008
The Synthetic Chemical Organic Manufacturers Association (SOCMA) has raised concerns over requirements for security vulnerability assessments (SVA) under the US Department of Homeland Security's (DHS) Chemical Facility Anti-Terrorism Act Standards (CFATS).
December 04, 2008
Reps. John D. Dingell (D-MI), current chairman of the Committee on Energy and Commerce in the US House and Representatives, and Bart Stupak (D-MI), chairman of that committee?s Oversight and Investigations Subcommittee, said that moving the Food and Drug Administration Globalization Act and other measures for drug and food safety will be a key priority for the next Congress.
December 03, 2008
A recent study shows life-science companies have difficulty in planning and executing change-management practices.
Asian countries are moving up the value chain for pharmaceutical outsourcing.
2009 will likely be a difficult period for emerging biopharmaceutical companies.
December 02, 2008
A recent Pharmaceutical Technology survey examined the level, sources, and reasons behind innovation in drug development and manufacturing. This article contains bonus online-exclusive material.